Self-medication among general population in the European Union: prevalence and associated factors
European Journal of Epidemiology · 2024-09 · 39 (9) · 977-990
DOI: 10.1007/s10654-024-01153-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Epidemiology, online erschienen am 18.09.2024. Verfasst von Spencer Yeamans und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Specialties and Public Health, Preventative Medicine and Public Health Area, Universidad Rey Juan Carlos, Alcorcon, Madrid, Spa…. Hauptthemen laut MEDLINE: Self Medication, European Union. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Rey Juan Carlos.
Abstract (Originalsprache)
Self-medication (SM) forms an important part of public health strategy. Nonetheless, little research has been performed to understand the current state of self-medication in the European Union (EU). Utilizing data from the third wave of the European Health Interview Surveys, this study finds an estimated SM prevalence of 34.3% in the EU (95%CI = 34.1-34.5%; n = 255,758). SM prevalence, as well as SM prevalence inequality between men and women, varies substantially between EU member countries. Via multivariable analysis, we also identify a number of variables associated with SM, most notably the substantial impact of health systems on SM behavior (Adjusted Odds Ratio [AOR] = 4.00; 95% Confidence Interval [95%CI] = 3.81–4.21). Several demographics are also associated with greater SM prevalence, including those aged 25–44 (versus ages 75+: AOR = 1.21; 95%CI = 1.12–1.31), women (AOR = 1.74; 95%CI = 1.68–1.81), immigrants born in other EU states (AOR = 1.16; 95%CI = 1.04–1.30), those with higher education (AOR = 1.83; 95%CI = 1.60–2.09), and urban dwellers (AOR = 1.14; 95%CI = 1.04–1.30). Additionally, long-standing health problems (AOR = 1.39; 95%CI = 1.33–1.45), visits to doctors (both general practitioners and specialists) (AOR = 1.21, 95%CIs = 1.15–1.26, 1.17–1.26), and unmet needs for health care due to waiting lists (AOR = 1.38; 95%CI = 1.23–1.55) or inability to afford medical examinations/treatment (AOR = 1.27; 95%CI = 1.12–1.42) serve as conditioners for SM. We also find that smoking (AOR = 1.05; 95%CI = 1.01–1.10), vaping (AOR = 1.19; 95%CI = 1.06–1.32), drinking alcohol (AOR = 1.23; 95%CI = 1.19–1.28), and higher levels of physical activity (AOR = 1.27; 95%CI = 1.22–1.32) are factors associated with SM. Analysis of these variables reveals that though women self-medicate more than men, the patterns that govern their consumption are similar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Specialties and Public Health, Preventative Medicine and Public Health Area, Universidad Rey Juan Carlos, Alcorcon, Madrid, Spain. spencer.yeamans@urjc.es.
- Department of Medical Specialties and Public Health, Preventative Medicine and Public Health Area, Universidad Rey Juan Carlos, Alcorcon, Madrid, Spain.
Förderung
- Universidad Rey Juan Carlos
Zitieren
APA
Yeamans, S., Gil-de-Miguel, Á., Hernández-Barrera, V., & Carrasco-Garrido, P. (2024). Self-medication among general population in the European Union: prevalence and associated factors. European Journal of Epidemiology, 39(9), 977-990. https://doi.org/10.1007/s10654-024-01153-1
Vancouver
Yeamans S, Gil-de-Miguel Á, Hernández-Barrera V, Carrasco-Garrido P. Self-medication among general population in the European Union: prevalence and associated factors. European Journal of Epidemiology. 2024;39(9):977-990. doi:10.1007/s10654-024-01153-1
BibTeX
@article{Yeamans2024,
author = {Yeamans, Spencer and Gil-de-Miguel, Ángel and Hernández-Barrera, Valentín and Carrasco-Garrido, Pilar},
title = {Self-medication among general population in the European Union: prevalence and associated factors},
journal = {European Journal of Epidemiology},
year = {2024},
volume = {39},
number = {9},
pages = {977--990},
doi = {10.1007/s10654-024-01153-1}
}
EUVIMED